Alternative Splicing of MEF2C pre-mRNA Controls Its Activity in Normal Myogenesis and Promotes Tumorigenicity in Rhabdomyosarcoma Cells*
暂无分享,去创建一个
[1] J. Davie,et al. TBX2 blocks myogenesis and promotes proliferation in rhabdomyosarcoma cells , 2014, International journal of cancer.
[2] A. Krainer,et al. Emerging Functions of SRSF1, Splicing Factor and Oncoprotein, in RNA Metabolism and Cancer , 2014, Molecular Cancer Research.
[3] T. Cooper,et al. The Mef2 transcription network is disrupted in myotonic dystrophy heart tissue, dramatically altering miRNA and mRNA expression. , 2014, Cell reports.
[4] P. Convertini,et al. MEF2C exon α: role in gene activation and differentiation. , 2013, Gene.
[5] J. Davie,et al. Loss of MEF2D expression inhibits differentiation and contributes to oncogenesis in rhabdomyosarcoma cells , 2013, Molecular Cancer.
[6] María Martín,et al. Activities at the Universal Protein Resource (UniProt) , 2013, Nucleic Acids Res..
[7] James R. Anderson,et al. Stress-induced isoforms of MDM2 and MDM4 correlate with high-grade disease and an altered splicing network in pediatric rhabdomyosarcoma. , 2013, Neoplasia.
[8] C. Keller,et al. Mechanisms of impaired differentiation in rhabdomyosarcoma , 2013, The FEBS journal.
[9] Zizhen Yao,et al. Tissue-specific splicing of a ubiquitously expressed transcription factor is essential for muscle differentiation. , 2013, Genes & development.
[10] Abraham P. Fong,et al. Comparison of Genome-Wide Binding of MyoD in Normal Human Myogenic Cells and Rhabdomyosarcomas Identifies Regional and Local Suppression of Promyogenic Transcription Factors , 2012, Molecular and Cellular Biology.
[11] Vassilios Ioannidis,et al. ExPASy: SIB bioinformatics resource portal , 2012, Nucleic Acids Res..
[12] T. Dang,et al. Inhibition of Notch3 signalling induces rhabdomyosarcoma cell differentiation promoting p38 phosphorylation and p21Cip1 expression and hampers tumour cell growth in vitro and in vivo , 2011, Cell Death and Differentiation.
[13] J. Davie,et al. Gamma Interferon Modulates Myogenesis through the Major Histocompatibility Complex Class II Transactivator, CIITA , 2011, Molecular and Cellular Biology.
[14] J. Davie,et al. Sequential association of myogenic regulatory factors and E proteins at muscle-specific genes , 2011, Skeletal Muscle.
[15] K. Baggerly,et al. Altered MEF2 isoforms in myotonic dystrophy and other neuromuscular disorders , 2010, Muscle & nerve.
[16] T. Tsukahara,et al. Alternative splicing of Mef2c promoted by Fox‐1 during neural differentiation in P19 cells , 2010, Genes to cells : devoted to molecular & cellular mechanisms.
[17] L. Wu,et al. Mastermind-like transcriptional co-activators: emerging roles in regulating cross talk among multiple signaling pathways , 2008, Oncogene.
[18] A. Aziz,et al. Protein Kinase A Represses Skeletal Myogenesis by Targeting Myocyte Enhancer Factor 2D , 2008, Molecular and Cellular Biology.
[19] E. Olson,et al. MEF2: a central regulator of diverse developmental programs , 2007, Development.
[20] J. Davie,et al. Target gene selectivity of the myogenic basic helix-loop-helix transcription factor myogenin in embryonic muscle. , 2007, Developmental biology.
[21] E. Olson,et al. Regulation of Skeletal Muscle Sarcomere Integrity and Postnatal Muscle Function by Mef2c , 2007, Molecular and Cellular Biology.
[22] E. Olson,et al. Histone Deacetylase 7 Maintains Vascular Integrity by Repressing Matrix Metalloproteinase 10 , 2006, Cell.
[23] M. D'Andrea,et al. Protein kinase C theta co‐operates with calcineurin in the activation of slow muscle genes in cultured myogenic cells , 2006, Journal of cellular physiology.
[24] M. Carli,et al. Results of a prospective minimal disseminated disease study in human rhabdomyosarcoma using three different molecular markers , 2006, Cancer.
[25] J. Harper,et al. A Calcium-Regulated MEF2 Sumoylation Switch Controls Postsynaptic Differentiation , 2006, Science.
[26] Thomas M. Harris,et al. Centronuclear myopathy in mice lacking a novel muscle-specific protein kinase transcriptionally regulated by MEF2. , 2005, Genes & development.
[27] T. Gulick,et al. Alternative Pre-mRNA Splicing Governs Expression of a Conserved Acidic Transactivation Domain in Myocyte Enhancer Factor 2 Factors of Striated Muscle and Brain* , 2005, Journal of Biological Chemistry.
[28] F. Barr,et al. Co‐expression of alternatively spliced forms of PAX3, PAX7, PAX3‐FKHR and PAX7‐FKHR with distinct DNA binding and transactivation properties in rhabdomyosarcoma , 2005, International journal of cancer.
[29] S. Tapscott,et al. A MyoD-generated feed-forward circuit temporally patterns gene expression during skeletal muscle differentiation. , 2004, Genes & development.
[30] T. Gulick,et al. Phosphorylation and Alternative Pre-mRNA Splicing Converge To Regulate Myocyte Enhancer Factor 2C Activity , 2004, Molecular and Cellular Biology.
[31] Wilson Nadruz,et al. Load-Induced Transcriptional Activation of c-jun in Rat Myocardium: Regulation by Myocyte Enhancer Factor 2 , 2003, Circulation research.
[32] S. Mohan,et al. Insulin‐Like Growth Factor I Effect on the Number of Osteoblast Progenitors Is Impaired in Ovariectomized Mice , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[33] Chun Li Zhang,et al. Class II Histone Deacetylases Act as Signal-Responsive Repressors of Cardiac Hypertrophy , 2002, Cell.
[34] C. Grozinger,et al. Calcium Regulates Transcriptional Repression of Myocyte Enhancer Factor 2 by Histone Deacetylase 4* , 2000, The Journal of Biological Chemistry.
[35] H. Youn,et al. Cabin1 represses MEF2-dependent Nur77 expression and T cell apoptosis by controlling association of histone deacetylases and acetylases with MEF2. , 2000, Immunity.
[36] Shen-Liang Chen,et al. The steroid receptor coactivator, GRIP-1, is necessary for MEF-2C-dependent gene expression and skeletal muscle differentiation. , 2000, Genes & development.
[37] E. Olson,et al. Signal-dependent activation of the MEF2 transcription factor by dissociation from histone deacetylases. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[38] M. Rudnicki,et al. Skeletal muscle development in the mouse embryo. , 2000, Histology and histopathology.
[39] G. Merlino,et al. Rhabdomyosarcoma – working out the pathways , 1999, Oncogene.
[40] B. Black,et al. Activated Notch Inhibits Myogenic Activity of the MADS-Box Transcription Factor Myocyte Enhancer Factor 2C , 1999, Molecular and Cellular Biology.
[41] E. Dodou,et al. The Saccharomyces cerevisiae MADS-box transcription factor Rlm1 is a target for the Mpk1 mitogen-activated protein kinase pathway , 1997, Molecular and cellular biology.
[42] Jiahuai Han,et al. Activation of the transcription factor MEF2C by the MAP kinase p38 in inflammation , 1997, Nature.
[43] L. Kedes,et al. Molecular mechanisms of myogenic coactivation by p300: direct interaction with the activation domain of MyoD and with the MADS box of MEF2C , 1997, Molecular and cellular biology.
[44] E. Olson,et al. Combinatorial control of muscle development by basic helix-loop-helix and MADS-box transcription factors. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[45] B. Black,et al. Cooperative activation of muscle gene expression by MEF2 and myogenic bHLH proteins , 1995, Cell.
[46] S. Elledge,et al. p53-independent expression of p21Cip1 in muscle and other terminally differentiating cells , 1995, Science.
[47] G. Hannon,et al. Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD , 1995, Science.
[48] G. Lyons,et al. Mef2 gene expression marks the cardiac and skeletal muscle lineages during mouse embryogenesis. , 1994, Development.
[49] N. Copeland,et al. A Mef2 gene that generates a muscle-specific isoform via alternative mRNA splicing , 1994, Molecular and cellular biology.
[50] B. Emanuel,et al. Fusion of a fork head domain gene to PAX3 in the solid tumour alveolar rhabdomyosarcoma , 1993, Nature Genetics.
[51] S. Lipton,et al. hMEF2C gene encodes skeletal muscle- and brain-specific transcription factors , 1993, Molecular and cellular biology.
[52] J. Biegel,et al. Rearrangement of the PAX3 paired box gene in the paediatric solid tumour alveolar rhabdomyosarcoma , 1993, Nature Genetics.
[53] E. Olson,et al. MEF2: a calcium-dependent regulator of cell division, differentiation and death. , 2002, Trends in biochemical sciences.
[54] B. Black,et al. Transcriptional control of muscle development by myocyte enhancer factor-2 (MEF2) proteins. , 1998, Annual review of cell and developmental biology.
[55] David D. McDonald,et al. Programs , 1984, CL.